WEZENLA 130 mg Concentrate for solution for infusion

Licence status
Authorised: 20/06/2024
Active substances
Ustekinumab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/24/1823/004
Licence holder
Amgen Technology (Ireland) UC

Product documents

Licence information

ATC code
L04AC05 ustekinumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/06/2024